In Vitro Analysis of the Antioxidant and Antiviral Activity of Embelin against Herpes Simplex Virus-1
Open Access
- 19 February 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (2), 434
- https://doi.org/10.3390/microorganisms9020434
Abstract
Herpes simplex virus-1 (HSV-1) causes a wide range of infections from mild to life-threatening in the human population. There are effective treatments for HSV-1 infections that are limited due HSV-1 latency and development of resistance to current therapeutics. The goal of this study was to investigate the antioxidant and antiviral effects of embelin on HSV-1 in cultured Vero cells. Oxidative stress was verified by an extensive production of a reactive oxygen species (ROS) H2O2. Vero cells were infected with a recombinant strain of HSV-1 and antiviral assays, time course attachment, penetration, and post penetration assays, confocal microscopy, qPCR, and antioxidant assays were conducted. Our results lead to the conclusion that embelin is noncytotoxic at concentrations tested ranging from 20 to 70 µM. Treatment of HSV-1 virions with embelin resulted in 98.7–100% inhibition and affected the early stage of HSV-1 infection of Vero cells, by inhibiting the attachment and penetration of HSV-1 virions to host cells. Treatment of virions with concentrations of embelin ranging from 35 to 60 µM significantly reduced the production of H2O2. In conclusion, embelin reduces oxidative damage caused by HSV-1 infection and is an effective antiviral to reduce the infection of HSV-1 in cultured Vero cells. Further studies are needed to explore the possibility of embelin as a medicinal agent.Keywords
This publication has 63 references indexed in Scilit:
- Effect of black tea extract on herpes simplex virus-1 infection of cultured cellsBMC Complementary and Alternative Medicine, 2013
- Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental modelsBMC Complementary and Alternative Medicine, 2013
- Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, the New, and the UnknownJournal of Immunology Research, 2012
- Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in ratsBiomedicine & Preventive Nutrition, 2011
- Novel Small-Molecule Inhibitor of Apurinic/Apyrimidinic Endonuclease 1 Blocks Proliferation and Reduces Viability of Glioblastoma CellsThe Journal of pharmacology and experimental therapeutics, 2010
- Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virusAntiviral Research, 2009
- Herpesvirus assembly: An updateVirus Research, 2009
- Uncoating the Herpes Simplex Virus GenomeJournal of Molecular Biology, 2007
- Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and BProceedings of the National Academy of Sciences of the United States of America, 2007
- The steady state level of catalase compound I in isolated hemoglobin‐free perfused rat liverFEBS Letters, 1970